3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
fludarabine phosphate
7
Peripheral Blood Stem Cell Transplantation
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Cyclosporine
5
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
Melphalan
3
Busulfan
3
Antilymphocyte Serum
3
Alemtuzumab
3
thymoglobulin
2
fludarabine
2
Thiotepa
2
Radiotherapy
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Darbepoetin alfa
2
Cyclosporins
2
plerixafor
1
merphos
1
ferrous sulfate
1
ferric gluconate
1
blinatumomab
1
Transplantation
1
Therapeutics
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Large Granular Lymphocytic
×
Imatinib Mesylate
×
Clear all
No trials found.